Company Filing History:
Years Active: 1989-1992
Title: Kawporn Sussangkarn: Innovator in Pharmaceutical Chemistry
Introduction
Kawporn Sussangkarn is a notable inventor based in Morgantown, WV (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that regulate immune responses in mammals. With a total of 2 patents, his work has implications for therapeutic applications.
Latest Patents
Sussangkarn's latest patents include innovative compounds such as pharmaceutically useful furyl substituted dihydroxyethylbutyrolactones. These compounds, specifically 2-(5-methylthiomethyl-2-furyl)-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone and 2-(5-methoxymethyl-2-furyl)-2-furyl(-2-hydroxy-3-keto-4-dihydroxyethylbutyrolactone, are designed to regulate the immune response in mammals. Additionally, he has developed condensation products of cyclic diketones and ascorbic acid, which have shown therapeutic activity through acid-catalyzed Michael reaction products. These compounds are derived from reactions of ascorbic acid with α,β-unsaturated alicyclic diketones containing 5 to 7 carbon atoms.
Career Highlights
Throughout his career, Sussangkarn has worked with various companies, including American Biotechnology Company and Theracel Corporation. His expertise in pharmaceutical chemistry has allowed him to contribute to advancements in drug development and therapeutic solutions.
Collaborations
Some of his notable coworkers include Gabor B. Fodor and Robert W. Veltri. Their collaborative efforts have furthered research in the field and enhanced the impact of their innovations.
Conclusion
Kawporn Sussangkarn's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to influence therapeutic advancements and immune response regulation.